Zynex Reports Third Quarter 2023 Financial Results

Q3 2023 Revenue Increased 20% to $49.9 Million; EPS $0.10 ENGLEWOOD, Colo., Oct. 26, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and…

Click here to view original post